139 related articles for article (PubMed ID: 38485147)
1. Precision medicine in cystic fibrosis: predictive role of forskolin-induced swelling assay.
Furstova E; Drevinek P; Novotna S; Libik M; Benesova K; Borek-Dohalska L; Sakmarova K; Modrak M; Macek M; Dousova T
Eur Respir J; 2024 Apr; 63(4):. PubMed ID: 38485147
[No Abstract] [Full Text] [Related]
2. Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients.
Boj SF; Vonk AM; Statia M; Su J; Vries RR; Beekman JM; Clevers H
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287550
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of the HCO(3)(-) conductance through the cystic fibrosis transmembrane conductance regulator anion channel by genistein and forskolin in murine duodenum.
Tuo B; Wen G; Seidler U
Br J Pharmacol; 2009 Nov; 158(5):1313-21. PubMed ID: 19788494
[TBL] [Abstract][Full Text] [Related]
4. Forskolin stimulates swelling-induced chloride current, not cardiac cystic fibrosis transmembrane-conductance regulator current, in human cardiac myocytes.
Oz MC; Sorota S
Circ Res; 1995 Jun; 76(6):1063-70. PubMed ID: 7538915
[TBL] [Abstract][Full Text] [Related]
5. Making precision medicine personal for cystic fibrosis.
Manfredi C; Tindall JM; Hong JS; Sorscher EJ
Science; 2019 Jul; 365(6450):220-221. PubMed ID: 31320522
[No Abstract] [Full Text] [Related]
6. [Challenges of personalized medicine for cystic fibrosis].
Corvol H; Taytard J; Tabary O; Le Rouzic P; Guillot L; Clement A
Arch Pediatr; 2015 Jul; 22(7):778-86. PubMed ID: 26021452
[TBL] [Abstract][Full Text] [Related]
7. A functional CFTR assay using primary cystic fibrosis intestinal organoids.
Dekkers JF; Wiegerinck CL; de Jonge HR; Bronsveld I; Janssens HM; de Winter-de Groot KM; Brandsma AM; de Jong NW; Bijvelds MJ; Scholte BJ; Nieuwenhuis EE; van den Brink S; Clevers H; van der Ent CK; Middendorp S; Beekman JM
Nat Med; 2013 Jul; 19(7):939-45. PubMed ID: 23727931
[TBL] [Abstract][Full Text] [Related]
8. Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assay.
Rodenburg LW; van der Windt IS; Dreyer HHM; Smits SMA; den Hertog-Oosterhoff LA; Aarts EM; Beekman JM; Amatngalim GD
STAR Protoc; 2023 Sep; 4(3):102337. PubMed ID: 37314920
[TBL] [Abstract][Full Text] [Related]
9. Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations.
de Winter-de Groot KM; Berkers G; Marck-van der Wilt REP; van der Meer R; Vonk A; Dekkers JF; Geerdink M; Michel S; Kruisselbrink E; Vries R; Clevers H; Vleggaar FP; Elias SG; Heijerman HGM; van der Ent CK; Beekman JM
J Cyst Fibros; 2020 Jul; 19(4):614-619. PubMed ID: 31735562
[TBL] [Abstract][Full Text] [Related]
10. Personalised medicine for cystic fibrosis: treating the basic defect.
Elborn JS
Eur Respir Rev; 2013 Mar; 22(127):3-5. PubMed ID: 23457158
[No Abstract] [Full Text] [Related]
11. Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression.
Muilwijk D; de Poel E; van Mourik P; Suen SWF; Vonk AM; Brunsveld JE; Kruisselbrink E; Oppelaar H; Hagemeijer MC; Berkers G; de Winter-de Groot KM; Heida-Michel S; Jans SR; van Panhuis H; van der Eerden MM; van der Meer R; Roukema J; Dompeling E; Weersink EJM; Koppelman GH; Vries R; Zomer-van Ommen DD; Eijkemans MJC; van der Ent CK; Beekman JM
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35086832
[TBL] [Abstract][Full Text] [Related]
12. Precision Genomic Medicine in Cystic Fibrosis.
Chang EH; Zabner J
Clin Transl Sci; 2015 Oct; 8(5):606-10. PubMed ID: 26073768
[TBL] [Abstract][Full Text] [Related]
13. Nasal epithelial cells as a gold-standard predictive model for personalized medicine in cystic fibrosis.
Pedemonte N
J Physiol; 2022 Mar; 600(6):1285-1286. PubMed ID: 35038767
[No Abstract] [Full Text] [Related]
14. Towards personalized medicine for cystic fibrosis patients with rare mutations.
Csanády L
J Physiol; 2024 Jan; 602(2):257-258. PubMed ID: 38167788
[No Abstract] [Full Text] [Related]
15. Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype.
Aalbers BL; Brunsveld JE; van der Ent CK; van den Eijnden JC; Beekman JM; Heijerman HGM
J Cyst Fibros; 2022 Mar; 21(2):254-257. PubMed ID: 35110005
[TBL] [Abstract][Full Text] [Related]
16. The cystic fibrosis airway milieu enhances rescue of F508del in a pre-clinical model.
Gentzsch M; Cholon DM; Quinney NL; Boyles SE; Martino MEB; Ribeiro CMP
Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30287473
[No Abstract] [Full Text] [Related]
17. Intestinal Current Measurements Detect Activation of Mutant CFTR in Patients with Cystic Fibrosis with the G551D Mutation Treated with Ivacaftor.
Graeber SY; Hug MJ; Sommerburg O; Hirtz S; Hentschel J; Heinzmann A; Dopfer C; Schulz A; Mainz JG; Tümmler B; Mall MA
Am J Respir Crit Care Med; 2015 Nov; 192(10):1252-5. PubMed ID: 26568242
[No Abstract] [Full Text] [Related]
18. Comparison of Organoid Swelling and
Graeber SY; van Mourik P; Vonk AM; Kruisselbrink E; Hirtz S; van der Ent CK; Mall MA; Beekman JM
Am J Respir Crit Care Med; 2020 Dec; 202(11):1589-1592. PubMed ID: 32687398
[No Abstract] [Full Text] [Related]
19. How many billions is enough? Prioritizing profits over patients with cystic fibrosis.
McGarry ME; Gibb ER; Laguna TA; O'Sullivan BP; Sawicki GS; Zobell JT
Pediatr Pulmonol; 2023 May; 58(5):1595-1597. PubMed ID: 36722731
[No Abstract] [Full Text] [Related]
20. Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids.
Vonk AM; van Mourik P; Ramalho AS; Silva IAL; Statia M; Kruisselbrink E; Suen SWF; Dekkers JF; Vleggaar FP; Houwen RHJ; Mullenders J; Boj SF; Vries R; Amaral MD; de Boeck K; van der Ent CK; Beekman JM
STAR Protoc; 2020 Jun; 1(1):100019. PubMed ID: 33111074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
